1Genomic Research Center for Lung and Breast/Ovarian Cancers, Korea University Anam Hospital, Seoul, Korea.
2Department of Internal Medicine and Division of Brain Korea 21 Project for Biomedical Science, Korea University College of Medicine, Seoul, Korea.
3Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
4Department of Internal Medicine, Inha University College of Medicine, Incheon, Korea.
Copyright © 2009 Korean Cancer Association
This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (A010250).
Baseline characteristics of study subjects
*including the small cell, large cell, and mixed cell carcinomas or undifferentiated carcinomas.
Polymorphism screening of STK11 promoter by direct sequencing
Distribution of genotype and their association with lung cancer risk in Korean lung cancer patients
*OR and confidence interval (95% CI) were calculated by unconditional logistic regression, adjusted for age, gender and smoking history.
Association analysis of haplotype with lung cancer risk in Korean lung cancer patients
*OR and confidence interval (95% CI) were calculated by unconditional logistic regression, adjusted for age, gender and smoking history.
*including the small cell, large cell, and mixed cell carcinomas or undifferentiated carcinomas.
*OR and confidence interval (95% CI) were calculated by unconditional logistic regression, adjusted for age, gender and smoking history.
*OR and confidence interval (95% CI) were calculated by unconditional logistic regression, adjusted for age, gender and smoking history.